REGINfo: Sanofi-Aventis - Pharmacie - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

COMPANY SEARCH RESULT

$Sanofi-Aventis: Click to view the issuer\'s details$

Last update : 29/03/2019 >View issuer details

2019.04.12 | 18:00 | Share History / Voting Rights and Number of Shares

puce Information concerning the total number of voting rights and shares - HTML (w)

2019.04.12 | 18:00 | Share History / Voting Rights and Number of Shares

puce Informations relatives au nombre total de droits de vote et d'actions - HTML (w)

2019.04.10 | 18:00 | Share Buybacks / Share redemption disclosures

puce Sanofi: Disclosure of trading in own shares - HTML (w)

2019.04.10 | 18:00 | Share Buybacks / Share redemption disclosures

puce Sanofi : Déclaration des transactions sur actions propres - HTML (w)

2019.04.08 | 07:00 | Permanent Information Releases / General Company News

puce Sanofi: Sanofi and Alnylam conclude research and option phase of 2014 rare disease alliance - HTML (w)

2019.04.08 | 07:00 | Permanent Information Releases / General Company News

puce Sanofi : Sanofi et Alnylam mettent un terme à la phase « Recherche et Options » de leur alliance dans les maladies rares nouée en 2014 - HTML (w)

2019.04.01 | 07:30 | Permanent Information Releases / Notification of availability

puce Sanofi: Availability of the Pre-quarterly Results Communication - HTML (w)

2019.04.01 | 07:30 | Permanent Information Releases / Notification of availability

puce Sanofi : Mise en ligne du document «Pre-quarterly Results Communication » - HTML (w)

2019.03.25 | 15:20 | Share History / Voting Rights and Number of Shares

puce Information concerning the total number of voting rights and shares - HTML (w)

2019.03.25 | 15:20 | Share History / Voting Rights and Number of Shares

puce Informations relatives au nombre total de droits de vote et d'actions - HTML (w)

2019.03.22 | 19:15 | Permanent Information Releases / General Company News

puce Sanofi: FDA issues Complete Response Letter for Zynquista(TM) (sotagliflozin) - HTML (w)

2019.03.22 | 19:15 | Permanent Information Releases / General Company News

puce Sanofi : La FDA publie une lettre de réponse complète au sujet de Zynquista(TM) (sotagliflozine) - HTML (w)

2019.03.15 | 21:01 | Permanent Information Releases / General Company News

puce Praluent® (alirocumab) now approved in European Union to reduce the risk of cardiovascular events in patients with established cardiovascular disease - HTML (w)

2019.03.15 | 21:01 | Permanent Information Releases / General Company News

puce Praluent (alirocumab) approuvé dans l'Union européenne pour réduire le risque d'événements cardiovasculaires chez les patients atteints d'une maladie cardiovasculaire établie - HTML (w)

2019.03.13 | 19:29 | Permanent Information Releases / Operations

puce Sanofi successfully prices EUR 2 billion of bond issues - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 2657